4.5 Article

Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer

出版社

WILEY
DOI: 10.1002/hed.25050

关键词

alcohol dehydrogenase-aldehyde dehydrogenase (ADH-ALDH) polymorphism; head and neck cancers; hypopharyngeal cancers; prognosis

资金

  1. Grants-in-Aid for Scientific Research [16K15581, 16H05481] Funding Source: KAKEN

向作者/读者索取更多资源

BackgroundThe purpose of this research was to investigate the association between alcohol dehydrogenase 1B (ADH1B) and aldehyde dehydrogenase 2 (ALDH2) polymorphisms and hypopharyngeal squamous cell carcinoma (SCC) survival. MethodsWe genotyped ADH1B (rs1229984) and ALDH2 (rs671) single nucleotide polymorphisms (SNPs) in 85 Japanese male patients with hypopharyngeal SCC. The independent prognostic values of ADH1B-ALDH2 genotypes were analyzed by univariate and multivariate proportional hazard Cox regression, taking well-known clinical risk factors into account. ResultsHeavy drinkers with ALDH2*2 allele resulted in significantly worse overall survival (OS; P = .028) and disease-free survival (DFS; P = .029) compared with other patients. Heavy drinkers with ALDH2*2 allele remained statistically significant in multivariate analysis for OS and DFS, indicating independent poor prognostic factor (hazard ratio [HR] 2.251; 95% confidence interval [CI] 1.018-4.975 and HR 2.261; 95% CI 1.021-5.006, respectively). ConclusionWe conclude that heavy drinkers with the ALDH2*2 allele are associated with poor outcome in hypopharyngeal SCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Efficacy of Spacers in Radiation Therapy for Locally Advanced Pancreatic Cancer: A Planning Study

Hiroki Kawaguchi, Yusuke Demizu, Naritoshi Mukumoto, Takeaki Ishihara, Daisuke Miyawaki, Shohei Komatsu, Hiroaki Akasaka, Makoto Shinoto, Yoshiyuki Shioyama, Katsumasa Nakamura, Takumi Fukumoto, Ryohei Sasaki

Summary: The study aimed to investigate the dosimetric effects of placing spacers in IMRT planning for LAPC patients. Results showed that appropriate spacer placement can improve the percentage of planning target volume receiving the prescribed dose, thus improving patient outcomes.

ANTICANCER RESEARCH (2021)

Letter Oncology

The first pediatric case of sacral Ewing sarcoma treated with space-making particle therapy

Daisuke Takagi, Yuri Morikawa, Michi Kamei, Hiroyuki Ogino, Hiromitsu Iwata, Naoko Maeda, Nobuhiro Akita, Takumi Fukumoto, Ryohei Sasaki, Satoshi Kondo

PEDIATRIC BLOOD & CANCER (2021)

Article Oncology

Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma

Hikaru Kubota, Daisuke Miyawaki, Naritoshi Mukumoto, Takeaki Ishihara, Megumi Matsumura, Takumi Hasegawa, Masaya Akashi, Naomi Kiyota, Hirotaka Shinomiya, Masanori Teshima, Ken-ichi Nibu, Ryohei Sasaki

Summary: V60 > 14% and oropharyngeal or oral cancer were identified as independent risk factors for osteoradionecrosis of the jaw (ORNJ). These findings could help to minimize the incidence of ORNJ in patients with head and neck squamous cell carcinoma treated with curative radiation therapy.

RADIATION ONCOLOGY (2021)

Article Otorhinolaryngology

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF-CRT) for locally advanced squamous cell carcinoma of the external auditory canal

Hirotaka Shinomiya, Natsumi Uehara, Takeshi Fujita, Daisuke Miyawaki, Yoshinori Imamura, Masanori Teshima, Akinobu Kakigi, Naomi Kiyota, Ryohei Sasaki, Ken-ichi Nibu

Summary: Chemoradiotherapy with docetaxel, cisplatin, and 5-FU for locally advanced external auditory canal cancer has shown favorable outcomes. A phase I trial determined the recommended and maximum tolerated dose of docetaxel in this treatment regimen, with the RD and MTD determined to be 40 mg/m(2) when used alongside cisplatin and 5-FU.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

A treatment planning study comparison between supine and prone position for different lung tumour locations using CyberKnife TPS

Hiroaki Akasaka, Kazufusa Mizonobe, Yuya Oki, Kazuyuki Uehara, Aya Harada, Shuichiro Miyazaki, Keiji Kitatani, Tomonori Yabuuchi, Takeaki Ishihara, Daisuke Miyawaki, Masao Nakayama, Naritoshi Mukumoto, Ryuichi Yada, Ai Nakaoka, Hikaru Kubota, Hiroki Kawaguchi, Satoshi Seno, Ryohei Sasaki, Hiroshi Mayahara

Summary: This study compared treatment planning for lung cancer in CyberKnife SBRT between prone and supine positions, finding that the prone set-up was more effective in reducing dose to normal lung tissue.

JOURNAL OF RADIOTHERAPY IN PRACTICE (2022)

Article Otorhinolaryngology

Blowing time ratio and high-resolution manometry to evaluate swallowing function of patients with oral and oropharyngeal cancer

Hirokazu Komatsu, Tatsuya Furukawa, Keisuke Iritani, Shun Tatehara, Miki Takahashi, Shinobu Iwaki, Yasumasa Kakei, Takumi Hasegawa, Masanori Teshima, Hirotaka Shinomiya, Naoki Otsuki, Kazunobu Hashikawa, Naomi Kiyota, Ryohei Sasaki, Masaya Akashi, Ken-ichi Nibu

Summary: This study evaluated the blowing time ratio as a screening tool for assessing swallowing pressure in patients treated for oral and oropharyngeal cancer. The results showed a significant correlation between the blowing time ratio and swallowing pressures in the oropharynx and velopharynx, supporting its usefulness in evaluating these pressures.

AURIS NASUS LARYNX (2022)

Article Gastroenterology & Hepatology

Space-Making Particle Therapy for Unresectable Hilar Cholangiocarcinoma

Yu Hashimoto, Shohei Komatsu, Kazuki Terashima, Daisuke Tsugawa, Hiroaki Yanagimoto, Masaki Suga, Yusuke Demizu, Sunao Tokumaru, Tomoaki Okimoto, Ryohei Sasaki, Tetsuo Ajiki, Takumi Fukumoto

Summary: This study evaluated the effectiveness of space-making particle therapy (SMPT) for the treatment of hilar cholangiocarcinoma (HC). The results showed improvements in dosimetric parameters and good treatment outcomes. SMPT could be a promising alternative for patients with unresectable HC.

DIGESTIVE SURGERY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Fiducial marker position affects target volume in stereotactic lung irradiation

Hiroaki Akasaka, Kazufusa Mizonobe, Yuya Oki, Kazuyuki Uehara, Masao Nakayama, Shuhei Tamura, Yoshiki Munetomo, Haruna Kawaguchi, Jun Ishida, Aya Harada, Takeaki Ishihara, Hikaru Kubota, Hiroki Kawaguchi, Ryohei Sasaki, Hiroshi Mayahara

Summary: This study investigated the relationship between the position of fiducial markers and the internal target volume (ITV) in lung cancer patients. The findings can help protect normal lung tissue from radiation exposure and improve target coverage.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2022)

Article Oncology

Reactive oxygen species-inducing titanium peroxide nanoparticles as promising radiosensitizers for eliminating pancreatic cancer stem cells

Mohammed Salah, Hiroaki Akasaka, Yasuyuki Shimizu, Kenta Morita, Yuya Nishimura, Hikaru Kubota, Hiroki Kawaguchi, Tomomi Sogawa, Naritoshi Mukumoto, Chiaki Ogino, Ryohei Sasaki

Summary: This study found that titanium peroxide nanoparticles combined with radiation have anti-cancer effects on radioresistant pancreatic cancer stem cells (CSCs). They can inhibit the proliferation and invasion abilities of CSCs, and suppress the growth of pancreatic tumors by generating reactive oxygen species (ROS). These findings suggest that the combination of TiOxNPs and radiation may be an effective therapeutic strategy for pancreatic CSCs.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Cell Biology

The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor

Yuntao Dai, Tetsuya Kawaguchi, Miki Nishio, Junji Otani, Hironori Tashiro, Yoshito Terai, Ryohei Sasaki, Tomohiko Maehama, Akira Suzuki

Summary: This study reveals that TIGD5 may function as a tumor suppressor in ovarian cancer (OC) rather than an oncogene. Patients with elevated TIGD5 mRNA expression have poor prognosis in OC, but overexpression of TIGD5 in OC cell lines unexpectedly inhibits cell growth and invasiveness. These findings highlight the potential important role of TIGD5 in the development of OC.

GENES TO CELLS (2022)

Article Oncology

Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan

Toshiyuki Takemori, Teruya Kawamoto, Hitomi Hara, Naomasa Fukase, Shuichi Fujiwara, Ikuo Fujita, Takuya Fujimoto, Masayuki Morishita, Kazumichi Kitayama, Shunsuke Yahiro, Tomohiro Miyamoto, Masanori Saito, Jun Sugaya, Katsuhiro Hayashi, Hiroyuki Kawashima, Tomoaki Torigoe, Tomoki Nakamura, Hiroya Kondo, Toru Wakamatsu, Munenori Watanuki, Munehisa Kito, Satoshi Tsukushi, Akihito Nagano, Hidetatsu Outani, Shunichi Toki, Shunji Nishimura, Hiroshi Kobayashi, Itsuo Watanabe, Yusuke Demizu, Ryohei Sasaki, Takumi Fukumoto, Takahiro Niikura, Ryosuke Kuroda, Toshihiro Akisue

Summary: This study retrospectively analyzed the clinical outcomes of patients with pelvic and retroperitoneal bone and soft tissue sarcoma (BSTS) in Japan. Osteosarcoma showed significantly worse overall survival (OS) and progression-free survival (PFS) compared to other sarcomas in the pelvis and retroperitoneum. Larger primary tumor size was the only poor prognostic factor associated with local control (LC).

CANCERS (2022)

Article Oncology

Prognostic Value of Radiomics Analysis of Skeletal Muscle After Radical Irradiation of Esophageal Cancer

Kazuma Iwashita, Hikaru Kubota, Riku Nishioka, Yuki Emoto, Daisuki Kawahara, Takeaki Ishihara, Daisuke Miyawaki, Ikuno Nishibuchi, Yasushi Nagata, Ryohei Sasaki

Summary: This study aimed to construct a prognostic survival model for esophageal cancer patients who underwent radical irradiation using skeletal muscle radiomics. The predictive model constructed by machine learning and LASSO algorithm showed good performance in predicting the survival of esophageal cancer patients, with high accuracy, specificity, sensitivity, and area under the concentration-time curve.

ANTICANCER RESEARCH (2023)

Article Oncology

Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial

Kazuhiro Kitajima, Junpei Kuyama, Takashi Kawahara, Tsuyoshi Suga, Tomoaki Otani, Shigeyasu Sugawara, Yumiko Kono, Yukihisa Tamaki, Ayumi Seko-Nitta, Yoshinobu Ishiwata, Kimiteru Ito, Akira Toriihara, Shiro Watanabe, Makoto Hosono, Hideaki Miyake, Shingo Yamamoto, Ryohei Sasaki, Mitsuhiro Narita, Koichiro Yamakado

Summary: This retrospective study investigated the efficacy of change in the automated bone scan index (aBSI) as an imaging biomarker for treatment response and survival prediction in mCRPC patients treated with Ra-223. The study analyzed data from 205 Japanese mCRPC patients who received Ra-223 treatment between July 2016 and August 2020. The results showed that changes in aBSI, alkaline phosphatase (ALP), and prostate-specific antigen (PSA) were significant prognostic factors for overall survival in these patients.

CANCERS (2023)

Article Materials Science, Biomaterials

In vivo stealthified molecularly imprinted polymer nanogels incorporated with gold nanoparticles for radiation therapy

Yukiya Kitayama, Takuya Yamada, Kentaro Kiguchi, Aoi Yoshida, Shuhei Hayashi, Hiroaki Akasaka, Kazunori Igarashi, Yuya Nishimura, Yu Matsumoto, Ryohei Sasaki, Eri Takano, Hirobumi Sunayama, Toshifumi Takeuchi

Summary: A novel stealth radiation sensitizer based on Au-embedded molecularly imprinted polymer nanogels (Au MIP-NGs) was developed for low-dose X-ray radiation therapy. It showed good affinity and selectivity towards human serum albumin, and improved the efficiency of pancreatic cancer treatment in mouse models.

JOURNAL OF MATERIALS CHEMISTRY B (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Effects of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-rich Fraction on ROS Generation in Proton Beam irradiated Human Colon Carcinoma Cells

Noor Nabilah Talik Sisin, Hiroaki Akasaka, Ryohei Sasaki, Takahiro Tominaga, Hayato Miura, Masashi Nishi, Moshi Geso, Nor Fazila Che Mat, Khairunisak Abdul Razak, Wan Nordiana Rahman

Summary: This study investigated the production of intracellular reactive oxygen species (ROS) in colon cancer cells under proton beam radiotherapy in the presence of radiosensitizers. The combination of Cis and BC, as well as individual BiONPs, showed potential as radiosensitizers for proton beam therapy.

POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING (2022)

暂无数据